利托那韦

CAS号
162990-01-4 ;155213-67-5
CCD编号
CCD00180242
分子式
C37 H48 N6 O5 S2
分子量
720.955

基本信息

产品名称: 利托那韦
CAS: 162990-01-4 ;155213-67-5
中文同义词: 利托那韦
英文同义词: THIAZOL-5-YLMETHYL (2S,3S,5S)-3-HYDROXY-5-((S)-2-(3-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)-3-METHYLUREIDO)-3-METHYLBUTANAMIDO)-1,6-DIPHENYLHEXAN-2-YLCARBAMATE ; RITONAVIR ; RTV ; ABT 538 ; (3S,4S,6S,9S)-4-HYDROXY-12-METHYL-9-(1-METHYLETHYL)-13-[2-(1-METHYLETHYL)-4-THIAZOLYL]-8,11-DIOXO-3,6-BIS(PHENYLMETHYL)-2,7,10,12-TETRAAZATRIDECANOIC ACID 5-THIAZOLYLMETHYL ESTER ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5R)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYL-HEXAN-2-YL]CARBAMATE ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[(2S)-3-METHYL-2-([METHYL(([2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL))CARBAMOYL]AMINO)BUTANAMIDO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; NORVIR SOFTGEL ; ((1S,2S,4S)-1-BENZYL-2-HYDROXY-4-((S)-2-[3-(2-ISOPROPYL-THIAZOL-4-YLMETHYL)-3-METHYL-UREIDO]-3-METHYL-BUTYRYLAMINO)-5-PHENYL-PENTYL)-CARBAMIC ACID THIAZOL-5-YLMETHYL ESTER ; NORVIR
MDL号: MFCD00927142
氢键受体数量: 11
氢键供体数量: 4
Smile: CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@@H]([C@H](Cc3ccccc3)NC(=O)OCc4cncs4)O
InChi: InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
InChiKey: InChIKey=NCDNCNXCDXHOMX-XGKFQTDJSA-N

性质

注解: GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

* If the product has intellectual property rights, a license granted is must or contact us.